Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 329

1.

The economic burden of depression in the United States: how did it change between 1990 and 2000?

Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, Corey-Lisle PK.

J Clin Psychiatry. 2003 Dec;64(12):1465-75.

PMID:
14728109
2.

The economic burden of depression in 1990.

Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER.

J Clin Psychiatry. 1993 Nov;54(11):405-18.

PMID:
8270583
3.

Cost of depression in Europe.

Sobocki P, Jönsson B, Angst J, Rehnberg C.

J Ment Health Policy Econ. 2006 Jun;9(2):87-98.

PMID:
17007486
4.

The economic burden of schizophrenia in the United States in 2002.

Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, Aggarwal J.

J Clin Psychiatry. 2005 Sep;66(9):1122-9.

PMID:
16187769
5.

The economic burden of depression in Sweden from 1997 to 2005.

Sobocki P, Lekander I, Borgström F, Ström O, Runeson B.

Eur Psychiatry. 2007 Apr;22(3):146-52. Epub 2006 Dec 27.

PMID:
17194573
7.

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association.

Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271.

PMID:
18308683
8.

Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.

Sullivan PW, Follin SL, Nichol MB.

Pharmacoeconomics. 2004;22(14):929-42.

PMID:
15362929
9.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
10.
11.

Depression: cost-of-illness studies in the international literature, a review.

Berto P, D'Ilario D, Ruffo P, Di Virgilio R, Rizzo F.

J Ment Health Policy Econ. 2000 Mar 1;3(1):3-10.

PMID:
11967432
12.

The economic burden of depression.

Stoudemire A, Frank R, Hedemark N, Kamlet M, Blazer D.

Gen Hosp Psychiatry. 1986 Nov;8(6):387-94.

PMID:
3491775
13.

[Direct and indirect diabetes costs in the world].

Logminiene Z, Norkus A, Valius L.

Medicina (Kaunas). 2004;40(1):16-26. Review. Lithuanian.

14.

The burden of selected digestive diseases in the United States.

Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R.

Gastroenterology. 2002 May;122(5):1500-11.

PMID:
11984534
15.

Depression: a neglected major illness.

Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER.

J Clin Psychiatry. 1993 Nov;54(11):419-24.

PMID:
8270584
16.

The economic burden of anxiety disorders in the 1990s.

Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, Ballenger JC, Fyer AJ.

J Clin Psychiatry. 1999 Jul;60(7):427-35.

PMID:
10453795
17.

The healthcare costs of sarcopenia in the United States.

Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R.

J Am Geriatr Soc. 2004 Jan;52(1):80-5.

PMID:
14687319
18.
19.

Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.

Birnbaum HG, White AG, Reynolds JL, Greenberg PE, Zhang M, Vallow S, Schein JR, Katz NP.

Clin J Pain. 2006 Oct;22(8):667-76.

PMID:
16988561
20.

Update: direct and indirect costs of arthritis and other rheumatic conditions--United States, 1997.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2004 May 14;53(18):388-9.

Supplemental Content

Support Center